Responsibilities

• Global Asset and Portfolio Strategy: Lead development of the global commercial strategy for the bispecific antibody, leveraging the early L3 strategic framework and aligning asset priorities with broader disease-area and portfolio strategies.
• Global Asset and Portfolio Strategy: Partner with asset and disease teams to define indication-specific commercial strategies that support the overall bispecific antibody opportunity.
• Global Asset and Portfolio Strategy: Provide commercial guidance and strategic input to support clinical development planning, target product profile refinement, and evidence-generation priorities.
• Market Insights, Forecasting, And Competitive Intelligence: Oversee market research and insight generation for the new asset in collaboration with disease-area, asset, brand strategy, and market research partners.
• Market Insights, Forecasting, And Competitive Intelligence: Guide forecasting, opportunity assessment, and market-shaping analyses to inform planning assumptions, investment decisions, and strategic trade-offs.
• Market Insights, Forecasting, And Competitive Intelligence: Establish a bispecific landscape tracking and data-monitoring plan to assess evolving performance, competitive dynamics, and implications for positioning.
• Launch Preparedness and Commercial Execution: Establish and manage key launch-planning milestones, timelines, and activities to support future commercialization readiness.
• Launch Preparedness and Commercial Execution: Drive early commercial planning activities, including market development, lexicon development, scientific platform development, and customer engagement planning.
• Launch Preparedness and Commercial Execution: Guide generic name, brand name, and trademark development work in partnership with relevant internal stakeholders.
• Cross-Functional and Regional Leadership: Build trusted relationships with global commercial disease, asset, and brand strategy teams, as well as clinical, regulatory, manufacturing, market access, medical affairs, HEOR, publications, forecasting, finance, legal, compliance, regional, and local partners.

Requirements

• Bachelor's degree.
• Minimum of 8 years of commercial experience in the pharmaceutical, biotechnology, including experience in Marketing, sales, market access, pricing, and or marketing support.
• Understanding of oncology market dynamics, scientific innovation, healthcare policy, reimbursement, and access considerations.
• Experience developing and implementing strategy in a complex, cross-functional environment.
• Strong business acumen, analytical capability, and ability to drive key initiatives forward.
• Demonstrated collaboration skills across commercial, cross-divisional, regional, and local teams.
• Strong leadership, problem-solving, written and verbal communication, and presentation skills.
• Ability to influence without authority and communicate clearly across the enterprise and to senior leadership.

Preferred

• Advanced degree, such as an MBA.
• Global marketing experience.
• Oncology experience.
• Launch planning or launch execution experience.
• Pipeline, early asset, or clinical development experience.
• Experience providing commercial input into target product profiles, regulatory filing strategy, launch readiness reviews, market research, organized customer engagement, demand and revenue forecasting, P&L forecasting, BD&L activities, product development teams, or agency partner management.
• Experience partnering with finance and business planning teams to support brand forecasting and S&OP processes.
• Previous team leadership experience.

Benefits

• We offer a comprehensive package of benefits. Available benefits include medical, dental, vision healthcare and other insurance benefits (for employee and family), retirement benefits, including 401(k), paid holidays, vacation, and compassionate and sick days.